These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24465544)

  • 21. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
    Ji M; Xu B; Jiang JT; Wu J; Li XD; Zhao WQ; Zhang HY; Zhou WJ; Wu CP
    Onkologie; 2013; 36(6):335-40. PubMed ID: 23774147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis.
    Shuai HL; Luo X; Yan RL; Li J; Chen DL
    Asian Pac J Cancer Prev; 2012; 13(12):6423-7. PubMed ID: 23464469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].
    Xu C; Wang X; Zhang Y; Li L
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):912-7. PubMed ID: 22152690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
    Zhao DY; Cheng L; Yu J; Shen H
    Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis.
    Chen J; Wang H; Li Z
    Pathol Oncol Res; 2019 Jul; 25(3):897-904. PubMed ID: 29285737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis.
    Wu J; Liu J; Zhou Y; Ying J; Zou H; Guo S; Wang L; Zhao N; Hu J; Lu D; Jin L; Li Q; Wang JC
    Clin Cancer Res; 2012 Jul; 18(14):3972-81. PubMed ID: 22705987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma.
    Yan L; Yanan D; Donglan S; Na W; Rongmiao Z; Zhifeng C
    Dis Esophagus; 2009; 22(5):396-401. PubMed ID: 19673050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
    Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
    Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H; Liu H; Knauss JL
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between polymorphisms in the XRCC1 gene and male infertility risk: A meta-analysis.
    Liu Z; Lin L; Yao X; Xing J
    Medicine (Baltimore); 2020 May; 99(18):e20008. PubMed ID: 32358378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of ERCC1‑118, XRCC1‑399 and GSTP1‑105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin‑based adjuvant chemotherapy.
    Liu YP; Ling Y; Qi QF; Zhang YP; Zhang CS; Zhu CT; Wang MH; Pan YD
    Mol Med Rep; 2013 Jun; 7(6):1904-11. PubMed ID: 23604281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
    Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
    PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer.
    Fan X; Xiu Q
    J Cancer Res Ther; 2015; 11(3):571-4. PubMed ID: 26458583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
    Jin ZY; Zhao XT; Zhang LN; Wang Y; Yue WT; Xu SF
    Genet Mol Res; 2014 Mar; 13(3):7617-25. PubMed ID: 24737519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia.
    Bănescu C; Duicu C; Trifa AP; Dobreanu M
    Leuk Lymphoma; 2014 Feb; 55(2):365-70. PubMed ID: 23662987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer.
    Ratnasinghe LD; Abnet C; Qiao YL; Modali R; Stolzenberg-Solomon R; Dong ZW; Dawsey SM; Mark SD; Taylor PR
    Cancer Lett; 2004 Dec; 216(2):157-64. PubMed ID: 15533591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.